Histone methylation patterns in astrocytes are influenced by age following ischemia

Epigenetics

Volumn 10, Issue 2, 2015, Pages 142-152

  Chisholm, Nioka C ^a   Henderson, Michael L ^a   Selvamani, Amutha ^a   Park, Min Jung ^a   Dindot, Scott ^b   Miranda, Rajesh C ^a   Sohrabji, Farida ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Acetylation; Aging; Epigenetics; H3K4me3; HDAC; Histone 3 lysine 4 trimethylation; Stroke; Transcription

Indexed keywords

DNA METHYLTRANSFERASE; ENDOTHELIN 1; H3K4ME3; H3K9ME3; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE METHYLTRANSFERASE; MICRORNA; PROTEIN; SIRTUIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ACYLTRANSFERASE; HISTONE; LYSINE; METHYLTRANSFERASE;

ADULT; AGE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL MOTILITY; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HISTONE ACETYLATION; HISTONE METHYLATION; ISCHEMIA; MIDDLE AGED; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ACETYLATION; ANIMAL; BRAIN CORTEX; BRAIN ISCHEMIA; CYTOLOGY; METABOLISM; METHYLATION; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALIA; RATTUS;

ACETYLATION; ACETYLTRANSFERASES; AGING; ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CEREBRAL CORTEX; FEMALE; HISTONES; LYSINE; METHYLATION; METHYLTRANSFERASES; RATS, SPRAGUE-DAWLEY;

EID: 84925009678     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2014.1001219     Document Type: Article

References (38)

1. Liu F, Yuan R, Benashski SE, McCullough LD. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009; 29:792-802; PMID:19223913; http://dx.doi.org/10.1038/jcbfm.2009.5
2. Selvamani A, Sohrabji F. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging 2010; 31:1618-28; PMID:18829137; http://dx.doi.org/10.1016/j.neurobiolaging.2008.08.014
3. Barreto G, White RE, Ouyang Y, Xu L, Giffard RG. Astrocytes: Targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 2011; 11:164-73; PMID:21521168; http://dx.doi.org/10.2174/187152411796011303
4. Cabezas R, Avila M, Gonzalez J, El-Bacha RS, Baez E, Garcia-Segura LM, Jurado Coronel JC, Capani F, Cardona-Gomez GP, Barreto GE. Astrocytic modulation of blood brain barrier: perspectives on parkinson’s disease. Front Cell Neurosci 2014; 8:211; PMID:25136294; http://dx.doi.org/10.3389/fncel.2014.00211
5. Lewis DK, Thomas KT, Selvamani A, Sohrabji F. Agerelated severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging 2012; 33:1123e1-112316; PMID:22154819; http://dx.doi.org/10.1016/j.neurobiolaging.2011.11.007
6. Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, Huber JD, O’Callaghan JP. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience 2010; 170:633-44; PMID:20633608; http://dx.doi.org/10.1016/j.neuroscience.2010.07.011
7. Quina AS, Buschbeck M, Di Croce L. Chromatin structure and epigenetics. Biochem Pharmacol 2006; 72:1563-9; PMID:16836980; http://dx.doi.org/10.1016/j.bcp.2006.06.016
8. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705; PMID:17320507
9. Wu P, Zuo X, Ji A. Stroke-induced microRNAs: The potential therapeutic role for stroke. Exp Ther Med 2012; 3:571-6; PMID:22969931
10. Selvamani A, Williams MH, Miranda RC, Sohrabji F. Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin Sci (Lond) 2014; 127:77-89; PMID:24428837
11. DosSantos Sant’Anna G, Rostirola Elsner V, Moyses F, Reck Cechinel L, Agustini Lovatel G, Rodrigues Siqueira I. Histone deacetylase activity is altered in brain areas from aged rats. Neurosci Lett 2013; 556:152-4; PMID:24140005; http://dx.doi.org/10.1016/j.neulet.2013.10.016
12. Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, Cota P, Wittnam JL, Gogol-Doering A, Opitz L, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010; 328:753-6; PMID:20448184; http://dx.doi.org/10.1126/science.1186088
13. Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet 2000; 25:294-7; PMID:10888876; http://dx.doi.org/10.1038/77046
14. Lopatina N, Haskell JF, Andrews LG, Poole JC, Saldanha S, Tollefsbol T. Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem 2002; 84:324-34; PMID:11787061; http://dx.doi.org/10.1002/jcb.10015
15. Endres M, Fan G, Meisel A, Dirnagl U, Jaenisch R. Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons. Neuroreport 2001; 12:3763-66; PMID:11726790; http://dx.doi.org/10.1097/00001756-200112040-00032
16. Endres M, Meisel A, Biniszkiewicz D, Namura S, Prass K, Ruscher K, Lipski A, Jaenisch R, Moskowitz MA, Dirnagl U. DNA methyltransferase contributes to delayed ischemic brain injury. J Neurosci 2000; 20:3175-81; PMID:10777781
17. Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012; 32:1677-98; PMID:22739623; http://dx.doi.org/10.1038/jcbfm.2012.88
18. Talwar T, Srivastava MV. Role of vascular endothelial growth factor and other growth factors in post-stroke recovery. Ann Indian Acad Neurol 2014; 17:1-6; PMID:24753650
19. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ. Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994; 5:89-97; PMID:7515293; http://dx.doi.org/10.1016/0955-2235(94)90019-1
20. Bernal GM, Peterson DA. Phenotypic and gene expression modification with normal brain aging in GFAPpositive astrocytes and neural stem cells. Aging Cell 2011; 10:466-82; PMID:21385309; http://dx.doi.org/10.1111/j.1474-9726.2011.00694.x
21. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111:1843-51; PMID:12813020; http://dx.doi.org/10.1172/JCI200317977
22. Wang Z, Tsai LK, Munasinghe J, Leng Y, Fessler EB, Chibane F, Leeds P, Chuang DM. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke 2012; 43:2430-6; PMID:22811460; http://dx.doi.org/10.1161/STROKEAHA.112.652545
23. Suzuki K, Ikegaya Y, Matsuura S, Kanai Y, Endou H, Matsuki N. Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes. J Cell Sci 2001; 114:3717-25; PMID:11707523
24. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008; 452:492-6; PMID:18337721; http://dx.doi.org/10.1038/nature06736
25. Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, Bar-Joseph Z, Cohen HY. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012; 483:218-21; PMID:22367546; http://dx.doi.org/10.1038/nature10815
26. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, et al. Genomic instability and aginglike phenotype in the absence of mammalian SIRT6. Cell 2006; 124:315-29; PMID:16439206; http://dx.doi.org/10.1016/j.cell.2005.11.044
27. Schwer B, Schumacher B, Lombard DB, Xiao C, Kurtev MV, Gao J, Schneider JI, Chai H, Bronson RT, Tsai LH, et al. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sci U S A 2010; 107:21790-4; PMID:21098266; http://dx.doi.org/10.1073/pnas.1016306107
28. Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F, Turner BM. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 2007; 282:4408-16; PMID:17166833; http://dx.doi.org/10.1074/jbc.M606773200
29. Chandrasekharan MB, Huang F, Sun ZW. Ubiquitination of histone H2B regulates chromatin dynamics by enhancing nucleosome stability. Proc Natl Acad Sci U S A 2009; 106:16686-91; PMID:19805358; http://dx.doi.org/10.1073/pnas.0907862106
30. Faraco G, Pancani T, Formentini L, Mascagni P, Fossati G, Leoni F, Moroni F, Chiarugi A. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 2006; 70:1876-84; PMID:16946032; http://dx.doi.org/10.1124/mol.106.027912
31. Yildirim F, Ji S, Kronenberg G, Barco A, Olivares R, Benito E, Dirnagl U, Gertz K, Endres M, Harms C, Meisel A. Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury. PLoS One 2014; 9:e95465; PMID:24748101; http://dx.doi.org/10.1371/journal.pone.0095465
32. Langley B, Brochier C, Rivieccio MA. Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke 2009; 40:2899-05; PMID:19478231; http://dx.doi.org/10.1161/STROKEAHA.108.540229
33. Huang PH, Chen CH, Chou CC, Sargeant AM, Kulp SK, Teng CM, Byrd JC, Chen CS. Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases. Mol Pharmacol 2011; 79:197-206; PMID:20959362; http://dx.doi.org/10.1124/mol.110.067702
34. Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 2009; 25:1754-60; PMID:19451168; http://dx.doi.org/10.1093/bioinformatics/btp324
35. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. Model-based analysis of ChIP-seq (MACS). Genome Biol 2008; 9:R137-2008-9-9-r137. Epub 2008 Sep 17; PMID:18798982; http://dx.doi.org/10.1186/gb-2008-9-9-r137
36. Zang C, Schones DE, Zeng C, Cui K, Zhao K, Peng W. A clustering approach for identification of enriched domains from histone modification ChIP-seq data. Bioinformatics 2009; 25:1952-8; PMID:19505939; http://dx.doi.org/10.1093/bioinformatics/btp340
37. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37:1-13; PMID:19033363; http://dx.doi.org/10.1093/nar/gkn923
38. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/nprot.2008.211